Medical Aspects of Chemical Warfare (2008) - The Black Vault

Vesicants141. Barillo DJ, McManus AT, Cancio LC, Sofer A, Goodwin CW. Burn center management of necrotizing fasciitis. J BurnCare Rehabil. 2003;24:127–132.142. Mendelson JA, Lindsey D. Sulfamylon (mafenide) and penicillin as expedient treatment of experimental massive openwounds with C. perfringens infection. J Trauma. 1962;2:239–261.143. Mendelson JA. Topical mafenide hydrochloride aqueous spray in initial management of massive contaminated woundswith devitalized tissue. Prehospital Disaster Med. 2001;16:172–174.144. Mendelson JA. The management of burns under conditions of limited resources using topical aqueous sulfamylon(mafenide) hydrochloride spray. J Burn Care Rehabil. 1997;18:238–244.145. Mendelson JA, Pratt HJ, Amato JJ, et al. Mafenide hydrochloride and mafenide acetate in spray and ointment formsas topical therapy C Perfringins contaminated massive wounds: experimental study. J Trauma. 1970;10:1132–1144.146. Smith WJ, Babin MC, Kiser RC, Casillas RP. Development of medical countermeasures to sulfur mustard vesication.In: Salem H, Katz SA, eds. Alternative Toxicological Methods. Boca Raton, Fla: CRC Press; 2003: 323–328.147. Babin MC, Ricketts K, Skvorak JP, Gazaway M, Mitcheltree LW, Casillas RP. Systemic administration of candidateantivesicants to protect against topically applied sulfur mustard in the mouse ear vesicant model (MEVM). J ApplToxicol. 2000;20:S141–S144.148. Casillas RP, Kiser RC, Truxall JA, et al. Therapeutic approaches to dermatotoxicity by sulfur mustard. I. Modulationof sulfur mustard-induced cutaneous injury in the mouse ear vesicant model. J Appl Toxicol. 2000;20:S145–S151.149. Amir A, Chapman S, Kadar T, Gozes Y, Sahar R, Allon N. Sulfur mustard toxicity in macrophages: effect of dexamethasone.J Appl Toxicol. 2000;20:S51–S58.150. Amir A, Turetz J, Chapman S, et al. Beneficial effects of topical anti-inflammatory drugs against sulfur-mustard-inducedocular lesions in rabbits. J Appl Toxicol. 2000;20:S109–S114.151. Husain K, Dube SN, Sugendran K, Singh R, Das Gupta S, Somani HD. Effect of topically applied sulphur mustard onantioxidant enzymes in blood cells and body tissues of rats. J Appl Toxicol. 1996;16(3):245–248.152. Kumar O, Sugendran K, Vijayaraghavan R. Protective effect of various antioxidants on the toxicity of sulphur mustardadministered to mice by inhalation or percutaneous routes. Chem Biol Interact. 2001;134(1):1–12.153. Naghii MR. Sulfur mustard intoxication, oxidative stress and antioxidants. Mil Med. 2002;167(7):573–575.154. Helfman T, Ovington L, Falanga V. Occlusive dressings and wound healing. Clin Dermatol. 1994;12(1):121–127.155. Chang H, Wind S, Kerstein MD. Moist wound healing. Dermatol Nurs. 1996;8(3):174–176.156. Kerstein MD. Moist wound healing: the clinical perspective. Ostomy Wound Manage. 1995;41(7A Suppl):37S–44S.157. Field CK, Kerstein MD. Overview of wound healing in a moist environment. Am J Surg. 1994;167(1A):2S–6S.158. Logan TP, Graham JS, Martin JL, Zallnick JE, Jakubowski EM, Braue EH. Detection and measurement of sulfur mustard(HD) offgassing from the weanling pig following exposure to saturated sulfur mustard vapor. J Appl Toxicol.2000;20:S199–204.159. Marsden AK. Accident department. In: Settle JAD, ed. Principles and Practice of Burns Management. New York, NY:Churchill Livingstone, 1996: 209–215.160. Johnson RM, Richard R. Partial-thickness burns: identification and management. Adv Skin Wound Care. 2003;6(4):178–189.303